Results 101 to 110 of about 163,708 (215)

Tracking tumor evolution via the prostate marker PSA: An individual post-operative study [PDF]

open access: yesarXiv, 2009
The progress of the prostate-specific antigen after radical prostatectomy is observed for a patient in order to extract information on the growth mode of the tumor cells. An initial fast-growth mode goes over to a slower power-law regime within two years of surgery.
arxiv  

Laparoscopic and robotic-assisted versus open radical prostatectomy for the treatment of localised prostate cancer.

open access: yesCochrane Database of Systematic Reviews, 2017
BACKGROUND Prostate cancer is commonly diagnosed in men worldwide. Surgery, in the form of radical prostatectomy, is one of the main forms of treatment for men with localised prostate cancer. Prostatectomy has traditionally been performed as open surgery,
D. Ilić   +5 more
semanticscholar   +1 more source

Novel evaluation of surgical activity recognition models using task-based efficiency metrics [PDF]

open access: yesInternational Journal of Computer Assisted Radiology and Surgery (IJCARS) 2019, 2019
Purpose: Surgical task-based metrics (rather than entire procedure metrics) can be used to improve surgeon training and, ultimately, patient care through focused training interventions. Machine learning models to automatically recognize individual tasks or activities are needed to overcome the otherwise manual effort of video review.
arxiv  

Robot-Assisted Radical Prostatectomy Is More Beneficial for Prostate Cancer Patients: A System Review and Meta-Analysis

open access: yesMedical Science Monitor, 2018
Background Robot-assisted radical prostatectomy (RARP) is increasingly used worldwide, but comparisons of perioperative, functional, and oncologic outcomes among RARP, laparoscopic radical prostatectomy (LRP), and open radical prostatectomy (ORP) remain ...
Yue-Feng Du   +7 more
semanticscholar   +1 more source

Is moderate hypofractionation accepted as a new standard of care in north america for prostate cancer patients treated with external beam radiotherapy? Survey of genitourinary expert radiation oncologists [PDF]

open access: yes, 2019
INTRODUCTION: Several recent randomized clinical trials have evaluated hypofractionated regimens against conventionally fractionated EBRT and shown similar effectiveness with conflicting toxicity results.
Chen, Yiyi   +5 more
core   +1 more source

Use of machine learning to predict early biochemical recurrence after robot‐assisted prostatectomy

open access: yesBJU International, 2018
To train and compare machine‐learning algorithms with traditional regression analysis for the prediction of early biochemical recurrence after robot‐assisted prostatectomy.
N. Wong   +3 more
semanticscholar   +1 more source

Optimal MRI sequences for 68Ga-PSMA-11 PET/MRI in evaluation of biochemically recurrent prostate cancer. [PDF]

open access: yes, 2017
BackgroundPET/MRI can be used for the detection of disease in biochemical recurrence (BCR) patients imaged with 68Ga-PSMA-11 PET. This study was designed to determine the optimal MRI sequences to localize positive findings on 68Ga-PSMA-11 PET of patients
Behr, Spencer C   +7 more
core   +1 more source

Combined Robotic Surgery for Double Renal Masses and Prostate Cancer: Myth or Reality?

open access: yesMedicina, 2020
With the widespread use of imaging modalities performed for the staging of prostate cancer, the incidental detection of synchronous tumors is increasing in frequency.
Giovanni Cochetti   +6 more
doaj   +1 more source

Postoperative complications of contemporary open and robot‐assisted laparoscopic radical prostatectomy using standardised reporting systems

open access: yesBJU International, 2018
To analyse time trends and contemporary rates of postoperative complications after radical prostatectomy (RP) and to compare the complication profile of open RP (ORP) and robot‐assisted laparoscopic RP (RALP) using standardised reporting systems.
R. Pompe   +9 more
semanticscholar   +1 more source

Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancer. [PDF]

open access: yes, 2014
BackgroundSipuleucel-T is a US Food and Drug Administration-approved immunotherapy for asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC). Its mechanism of action is not fully understood.
Amling, Christopher L   +12 more
core   +2 more sources

Home - About - Disclaimer - Privacy